{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:24:25Z","timestamp":1791606265209,"version":"4.3.4"},"reference-count":147,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":250,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic rhinosinusitis with nasal polyps (CRSwNP) is an inflammatory disorder of the sinonasal mucosa, predominantly characterized by epithelial dysfunction and chronic heterogeneous mucosal inflammation. CRSwNP and asthma are common comorbidities with overlapping pathophysiology, epithelial impairment, and activation of downstream type 2 inflammation. Thymic stromal lymphopoietin (TSLP) is an epithelial cytokine that sits at the top of the immunological cascade and initiates and amplifies type 2-dependent and -independent inflammatory responses. Although the role of TSLP in asthma has been well described, the role of TSLP in CRSwNP has yet to be comprehensively outlined. This review examines the evidence for TSLP as a key factor in CRSwNP pathogenesis. We explore what is known about TSLP expression patterns within the sinonasal mucosa, finding that TSLP expression is increased in patients with CRSwNP compared with healthy patients, and in eosinophilic- versus non-eosinophilic CRSwNP. We discuss the impact of environmental triggers and genetic factors on TSLP expression and activity, as well as other upstream regulators of TSLP signaling. We then consider the known mechanisms and effects of TSLP signaling on the recruitment and activation of various immune and structural cell types in CRSwNP. Finally, we consider the available evidence on the therapeutic potential of targeting TSLP signaling for the treatment of CRSwNP and discuss ongoing trials of promising therapeutic candidates.<\/jats:p>","DOI":"10.1093\/cei\/uxaf041","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:47:39Z","timestamp":1756900059000},"source":"Crossref","is-referenced-by-count":10,"title":["Thymic stromal lymphopoietin as a therapeutic target in patients with chronic rhinosinusitis and nasal polyps"],"prefix":"10.1093","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0745-2379","authenticated-orcid":false,"given":"Anju T","family":"Peters","sequence":"first","affiliation":[{"name":"Division of Allergy and Immunology, Feinberg School of Medicine, Northwestern University , Chicago, IL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph K","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology \u2013 Head & Neck Surgery, Eastern Virginia Medical School , Norfolk, VA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Heffler","sequence":"additional","affiliation":[{"name":"Personalized Medicine Asthma and Allergy Unit, IRCCS Humanitas Research Hospital , Milan ,","place":["Italy"]},{"name":"Department of Biomedical Sciences, Humanitas University , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freyja","family":"McClenahan","sequence":"additional","affiliation":[{"name":"PharmaGenesis London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Caveney","sequence":"additional","affiliation":[{"name":"Global Development, Inflammation, R&D, Amgen , Thousand Oaks, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tham T","family":"Le","sequence":"additional","affiliation":[{"name":"BioPharmaceuticals Medical, AstraZeneca , Gaithersburg, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Megally","sequence":"additional","affiliation":[{"name":"Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca , Gaithersburg, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D","family":"Spahn","sequence":"additional","affiliation":[{"name":"Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca , Wilmington, DE ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Foster","sequence":"additional","affiliation":[{"name":"Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca , Gaithersburg, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D","family":"Sherrill","sequence":"additional","affiliation":[{"name":"Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca , Gaithersburg, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"2025091922215242600_CIT0001","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jaip.2020.09.063","article-title":"Chronic rhinosinusitis with nasal polyps and asthma","volume":"9","author":"Laidlaw","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025091922215242600_CIT0002","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.jaip.2022.03.002","article-title":"Chronic rhinosinusitis with nasal polyps: quality of life in the biologics era","volume":"10","author":"Mullol","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025091922215242600_CIT0003","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/alr.22741","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis 2021","volume":"11","author":"Orlandi","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"2025091922215242600_CIT0004","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhin20.600","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"2025091922215242600_CIT0005","doi-asserted-by":"publisher","first-page":"316","DOI":"10.4193\/Rhino16.211","article-title":"Symptoms of chronic rhinosinusitis differentially impact general health-related quality of life","volume":"54","author":"Hoehle","year":"2016","journal-title":"Rhinology"},{"key":"2025091922215242600_CIT0006","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.jaip.2018.10.014","article-title":"Clinical characteristics of patients with chronic rhinosinusitis without nasal polyps in an academic setting","volume":"7","author":"Benjamin","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025091922215242600_CIT0007","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","article-title":"Chronic rhinosinusitis with nasal polyps","volume":"4","author":"Stevens","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025091922215242600_CIT0008","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1080\/03007995.2020.1815682","article-title":"Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis","volume":"36","author":"Chen","year":"2020","journal-title":"Curr Med Res Opin"},{"key":"2025091922215242600_CIT0009","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.alit.2014.12.006","article-title":"Immunopathology of chronic rhinosinusitis","volume":"64","author":"Kato","year":"2015","journal-title":"Allergol Int"},{"key":"2025091922215242600_CIT0010","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jaci.2016.05.041","article-title":"Diversity of T(H) cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania","volume":"138","author":"Wang","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0011","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00408-023-00603-z","article-title":"Prevalence and severity distribution of type 2 inflammation-related comorbidities among patients with asthma, chronic rhinosinusitis with nasal polyps, and atopic dermatitis","volume":"201","author":"Khan","year":"2023","journal-title":"Lung"},{"key":"2025091922215242600_CIT0012","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jaci.2020.08.036","article-title":"A substantial neutrophilic inflammation as regular part of severe type 2 chronic rhinosinusitis with nasal polyps","volume":"147","author":"Delemarre","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0013","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1016\/j.jaci.2021.11.023","article-title":"Elevation of activated neutrophils in chronic rhinosinusitis with nasal polyps","volume":"149","author":"Poposki","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0014","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.2147\/JIR.S377301","article-title":"An integrated analysis of inflammatory endotypes and clinical characteristics in chronic rhinosinusitis with nasal polyps","volume":"15","author":"Hao","year":"2022","journal-title":"J Inflamm Res"},{"key":"2025091922215242600_CIT0015","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.jaci.2008.07.008","article-title":"Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease","volume":"122","author":"Zhang","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0016","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1016\/j.jaip.2019.05.009","article-title":"Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis","volume":"7","author":"Stevens","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025091922215242600_CIT0017","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jaci.2016.06.063","article-title":"Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois","volume":"139","author":"Tan","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0018","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jaci.2016.09.048","article-title":"Large-scale gene expression profiling reveals distinct type 2 inflammatory patterns in chronic rhinosinusitis subtypes","volume":"139","author":"Tyler","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0019","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.anai.2023.08.021","article-title":"Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry","volume":"132","author":"Scelo","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2025091922215242600_CIT0020","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1183\/13993003.00779-2015","article-title":"Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort","volume":"46","author":"Shaw","year":"2015","journal-title":"Eur Respir J"},{"key":"2025091922215242600_CIT0021","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1002\/lary.23979","article-title":"Subclassification of chronic rhinosinusitis","volume":"123","author":"Han","year":"2013","journal-title":"Laryngoscope"},{"key":"2025091922215242600_CIT0022","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1080\/1744666X.2018.1512407","article-title":"Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps","volume":"14","author":"Heffler","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"2025091922215242600_CIT0023","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.jaci.2012.05.052","article-title":"Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-\u03b3 and IL-4","volume":"130","author":"Soyka","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0024","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jaci.2016.03.050","article-title":"Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients","volume":"139","author":"Wawrzyniak","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0025","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/cea.12471","article-title":"Elevated presence of myeloid dendritic cells in nasal polyps of patients with chronic rhinosinusitis","volume":"45","author":"Poposki","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"2025091922215242600_CIT0026","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jaci.2011.01.022","article-title":"Mast cell-associated alveolar inflammation in patients with atopic uncontrolled asthma","volume":"127","author":"Andersson","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0027","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1164\/rccm.201002-0295OC","article-title":"Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program","volume":"183","author":"Balzar","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2025091922215242600_CIT0028","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.jaci.2018.10.040","article-title":"Innate immune crosstalk in asthmatic airways: Innate lymphoid cells coordinate polarization of lung macrophages","volume":"143","author":"Kim","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0029","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1111\/all.13197","article-title":"Airway basophils are increased and activated in eosinophilic asthma","volume":"72","author":"Suzuki","year":"2017","journal-title":"Allergy"},{"key":"2025091922215242600_CIT0030","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1111\/all.16092","article-title":"Skin, gut, and lung barrier: physiological interface and target of intervention for preventing and treating allergic diseases","volume":"79","author":"Berni Canani","year":"2024","journal-title":"Allergy"},{"key":"2025091922215242600_CIT0031","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/194589240501900401","article-title":"Staphylococcal exotoxins and nasal polyposis: analysis of systemic and local responses","volume":"19","author":"Tripathi","year":"2005","journal-title":"Am J Rhinol"},{"key":"2025091922215242600_CIT0032","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1080\/14728222.2020.1783242","article-title":"Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma","volume":"24","author":"Gauvreau","year":"2020","journal-title":"Expert Opin Ther Targets"},{"key":"2025091922215242600_CIT0033","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.3389\/fimmu.2018.01595","article-title":"Thymic stromal lymphopoietin isoforms, inflammatory disorders, and cancer","volume":"9","author":"Varricchi","year":"2018","journal-title":"Front Immunol"},{"key":"2025091922215242600_CIT0034","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1084\/jem.20051135","article-title":"TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand","volume":"202","author":"Ito","year":"2005","journal-title":"J Exp Med"},{"key":"2025091922215242600_CIT0035","doi-asserted-by":"publisher","first-page":"2301619","DOI":"10.1183\/13993003.01619-2023","article-title":"Airway remodelling in asthma and the epithelium: on the edge of a new era","volume":"63","author":"Varricchi","year":"2024","journal-title":"Eur Respir J"},{"key":"2025091922215242600_CIT0036","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jaci.2013.04.005","article-title":"Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis","volume":"132","author":"Nagarkar","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0037","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/1753425914523460","article-title":"Eosinophilic inflammation of chronic rhinosinusitis with nasal polyps is related to OX40 ligand expression","volume":"21","author":"Boita","year":"2015","journal-title":"Innate Immun"},{"key":"2025091922215242600_CIT0038","doi-asserted-by":"publisher","first-page":"530488","DOI":"10.3389\/fimmu.2021.530488","article-title":"Elevated microRNA-21 is a brake of inflammation involved in the development of nasal polyps","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"key":"2025091922215242600_CIT0039","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.jaci.2022.11.029","article-title":"Evidence that oncostatin M synergizes with IL-4 signaling to induce TSLP expression in chronic rhinosinusitis with nasal polyps","volume":"151","author":"Wang","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0040","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1177\/039463201102400322","article-title":"The expression of TSLP receptor in chronic rhinosinusitis with and without nasal polyps","volume":"24","author":"Boita","year":"2011","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2025091922215242600_CIT0041","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/alr.22315","article-title":"Translating transcription: proteomics in chronic rhinosinusitis with nasal polyps reveals significant discordance with messenger RNA expression","volume":"9","author":"Workman","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"2025091922215242600_CIT0042","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s00405-019-05379-8","article-title":"Increased TSLP, IL-33, IL-25, IL-19, IL 21 and amphiregulin (AREG) levels in chronic rhinosinusitis with nasal polyp","volume":"276","author":"Dogan","year":"2019","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2025091922215242600_CIT0043","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1111\/all.13552","article-title":"Epithelial activators of type 2 inflammation: elevation of thymic stromal lymphopoietin, but not IL-25 or IL-33, in chronic rhinosinusitis with nasal polyps in Chicago, Illinois","volume":"73","author":"Ogasawara","year":"2018","journal-title":"Allergy"},{"key":"2025091922215242600_CIT0044","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/MAJ.0b013e3181f20489","article-title":"Role of thymic stromal lymphopoietin in the pathogenesis of nasal polyposis","volume":"341","author":"Liu","year":"2011","journal-title":"Am J Med Sci"},{"key":"2025091922215242600_CIT0045","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4193\/Rhino14.078","article-title":"Comparative analysis of cytokine release from epithelial cell cultures of the upper airway","volume":"53","author":"Shiozawa","year":"2015","journal-title":"Rhinology"},{"key":"2025091922215242600_CIT0046","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.jaci.2023.01.030","article-title":"Type 2 inflammation drives an airway basal stem cell program through insulin receptor substrate signaling","volume":"151","author":"Wang","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0047","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/alr.21082","article-title":"Clinical severity and epithelial endotypes in chronic rhinosinusitis","volume":"3","author":"Lam","year":"2013","journal-title":"Int Forum Allergy Rhinol"},{"key":"2025091922215242600_CIT0048","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2500\/ajra.2015.29.4176","article-title":"Interleukin-25 and interleukin-33 as mediators of eosinophilic inflammation in chronic rhinosinusitis","volume":"29","author":"Lam","year":"2015","journal-title":"Am J Rhinol Allergy"},{"key":"2025091922215242600_CIT0049","doi-asserted-by":"publisher","first-page":"e0171047","DOI":"10.1371\/journal.pone.0171047","article-title":"Impact of chronic rhinosinusitis on severe asthma patients","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"2025091922215242600_CIT0050","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.55730\/1300-0144.5418","article-title":"Stable and exacerbation period serum cytokine and periostin levels of the five distinct phenotypes of severe asthma","volume":"52","author":"T\u00fcrk","year":"2022","journal-title":"Turk J Med Sci"},{"key":"2025091922215242600_CIT0051","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1164\/rccm.201402-0234OC","article-title":"Disease-specific T-helper cell polarizing function of lesional dendritic cells in different types of chronic rhinosinusitis with nasal polyps","volume":"190","author":"Shi","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2025091922215242600_CIT0052","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3390\/biom10020326","article-title":"Reduced local response to corticosteroids in eosinophilic chronic rhinosinusitis with asthma","volume":"10","author":"Kobayashi","year":"2020","journal-title":"Biomolecules"},{"key":"2025091922215242600_CIT0053","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1111\/all.12667","article-title":"Interaction of thymic stromal lymphopoietin, IL-33, and their receptors in epithelial cells in eosinophilic chronic rhinosinusitis with nasal polyps","volume":"70","author":"Liao","year":"2015","journal-title":"Allergy"},{"key":"2025091922215242600_CIT0054","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1177\/1945892419835333","article-title":"Expression of IL-25, IL-33, and thymic stromal lymphopoietin in nasal polyp gland duct epithelium in patients with chronic rhinosinusitis","volume":"33","author":"Nagata","year":"2019","journal-title":"Am J Rhinol Allergy"},{"key":"2025091922215242600_CIT0055","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.3390\/ijms21082693","article-title":"Nasal epithelial cells activated with Alternaria and house dust mite induce not only Th2 but also Th1 immune responses","volume":"21","author":"Shin","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025091922215242600_CIT0056","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1089\/jir.2015.0058","article-title":"Epithelial cell-derived cytokines contribute to the pathophysiology of eosinophilic chronic rhinosinusitis","volume":"36","author":"Kouzaki","year":"2016","journal-title":"J Interferon Cytokine Res"},{"key":"2025091922215242600_CIT0057","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000346929","article-title":"Clinical characteristics and expression of thymic stromal lymphopoetin in eosinophilic and non-eosinophilic chronic rhinosinusitis","volume":"75","author":"Ouyang","year":"2013","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"2025091922215242600_CIT0058","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41586-018-0449-8","article-title":"Allergic inflammatory memory in human respiratory epithelial progenitor cells","volume":"560","author":"Ordovas-Montanes","year":"2018","journal-title":"Nature"},{"key":"2025091922215242600_CIT0059","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.alit.2024.04.001","article-title":"Role of basal cells in nasal polyp epithelium in the pathophysiology of eosinophilic chronic rhinosinusitis (eCRS)","volume":"73","author":"Kawakita","year":"2024","journal-title":"Allergol Int"},{"key":"2025091922215242600_CIT0060","doi-asserted-by":"publisher","first-page":"110559","DOI":"10.1016\/j.intimp.2023.110559","article-title":"Hypoxia induces the production of epithelial-derived cytokines in eosinophilic chronic rhinosinusitis with nasal polyps","volume":"121","author":"Zhang","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"2025091922215242600_CIT0061","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jaci.2018.03.019","article-title":"Solitary chemosensory cells are a primary epithelial source of IL-25 in patients with chronic rhinosinusitis with nasal polyps","volume":"142","author":"Kohanski","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0062","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.jaci.2016.08.040","article-title":"Proprotein convertases generate a highly functional heterodimeric form of thymic stromal lymphopoietin in humans","volume":"139","author":"Poposki","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0063","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.humimm.2012.11.004","article-title":"Polymorphisms in thymic stromal lymphopoietin gene demonstrate a gender and nasal polyposis-dependent association with chronic rhinosinusitis","volume":"74","author":"Zhang","year":"2013","journal-title":"Hum Immunol"},{"key":"2025091922215242600_CIT0064","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13223-019-0389-3","article-title":"Association between methylation in nasal epithelial TSLP gene and chronic rhinosinusitis with nasal polyps","volume":"15","author":"Li","year":"2019","journal-title":"Allergy Asthma Clin Immunol"},{"key":"2025091922215242600_CIT0065","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2500\/ajra.2015.29.4129","article-title":"The seasonality of respiratory viruses in patients with chronic rhinosinusitis","volume":"29","author":"Lima","year":"2015","journal-title":"Am J Rhinol Allergy"},{"key":"2025091922215242600_CIT0066","doi-asserted-by":"publisher","first-page":"2643297","DOI":"10.1155\/2016\/2643297","article-title":"Release of type 2 cytokines by epithelial cells of nasal polyps","volume":"2016","author":"Boita","year":"2016","journal-title":"J Immunol Res"},{"key":"2025091922215242600_CIT0067","doi-asserted-by":"publisher","first-page":"e0152808","DOI":"10.1371\/journal.pone.0152808","article-title":"Specific induction of TSLP by the viral RNA analogue Poly(I:C) in primary epithelial cells derived from nasal polyps","volume":"11","author":"Golebski","year":"2016","journal-title":"PLoS One"},{"key":"2025091922215242600_CIT0068","doi-asserted-by":"publisher","first-page":"e55472","DOI":"10.1371\/journal.pone.0055472","article-title":"Activated human nasal epithelial cells modulate specific antibody response against bacterial or viral antigens","volume":"8","author":"Yeh","year":"2013","journal-title":"PLoS One"},{"key":"2025091922215242600_CIT0069","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1164\/rccm.201710-2112OC","article-title":"Staphylococcus aureus induces a mucosal type 2 immune response via epithelial cell-derived cytokines","volume":"198","author":"Lan","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2025091922215242600_CIT0070","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/alr.21566","article-title":"P-glycoprotein regulates Staphylococcus aureus enterotoxin B-stimulated interleukin-5 and thymic stromal lymphopoietin secretion in organotypic mucosal explants","volume":"6","author":"Bleier","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"2025091922215242600_CIT0071","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.alit.2016.06.011","article-title":"The effect of calprotectin on TSLP and IL-25 production from airway epithelial cells","volume":"66","author":"Kato","year":"2017","journal-title":"Allergol Int"},{"key":"2025091922215242600_CIT0072","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.4049\/jimmunol.1000252","article-title":"Thymic stromal lymphopoietin in cigarette smoke-exposed human airway smooth muscle","volume":"185","author":"Smelter","year":"2010","journal-title":"J Immunol"},{"key":"2025091922215242600_CIT0073","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.jaci.2008.09.022","article-title":"Cigarette smoke extract induces thymic stromal lymphopoietin expression, leading to T(H)2-type immune responses and airway inflammation","volume":"122","author":"Nakamura","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0074","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/alr.21955","article-title":"Impact of tobacco smoke on upper airway dendritic cell accumulation and regulation by sinonasal epithelial cells","volume":"7","author":"Mulligan","year":"2017","journal-title":"Int Forum Allergy Rhinol"},{"key":"2025091922215242600_CIT0075","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4168\/aair.2020.12.1.56","article-title":"Particulate matter 2.5 causes deficiency in barrier integrity in human nasal epithelial cells","volume":"12","author":"Xian","year":"2020","journal-title":"Allergy Asthma Immunol Res"},{"key":"2025091922215242600_CIT0076","doi-asserted-by":"publisher","first-page":"e12019","DOI":"10.1002\/clt2.12029","article-title":"Budesonide repairs decreased barrier integrity of eosinophilic nasal polyp epithelial cells caused by PM2.5","volume":"11","author":"Ma","year":"2021","journal-title":"Clin Transl Allergy"},{"key":"2025091922215242600_CIT0077","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.2500\/ajra.2010.24.3436","article-title":"Synergistic induction of thymic stromal lymphopoietin by tumor necrosis factor alpha and Th2 cytokine in nasal polyp fibroblasts","volume":"24","author":"Nonaka","year":"2010","journal-title":"Am J Rhinol Allergy"},{"key":"2025091922215242600_CIT0078","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1165\/rcmb.2017-0325OC","article-title":"Expression and functional analysis of CST1 in intractable nasal polyps","volume":"59","author":"Kato","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2025091922215242600_CIT0079","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jaci.2019.07.009","article-title":"The IL-37-Mex3B-Toll-like receptor 3 axis in epithelial cells in patients with eosinophilic chronic rhinosinusitis with nasal polyps","volume":"145","author":"Liu","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0080","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1164\/rccm.201603-0529OC","article-title":"Endogenous protease inhibitors in airway epithelial cells contribute to eosinophilic chronic rhinosinusitis","volume":"195","author":"Kouzaki","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2025091922215242600_CIT0081","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0136-8","article-title":"Biological function of eosinophil extracellular traps in patients with severe eosinophilic asthma","volume":"50","author":"Choi","year":"2018","journal-title":"Exp Mol Med"},{"key":"2025091922215242600_CIT0082","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/all.13997","article-title":"Eosinophil extracellular traps activate type 2 innate lymphoid cells through stimulating airway epithelium in severe asthma","volume":"75","author":"Choi","year":"2020","journal-title":"Allergy"},{"key":"2025091922215242600_CIT0083","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1165\/rcmb.2009-0168OC","article-title":"Thymic stromal lymphopoietin induces chemotactic and prosurvival effects in eosinophils: implications in allergic inflammation","volume":"43","author":"Wong","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2025091922215242600_CIT0084","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1476-7961-10-8","article-title":"IL-3 and TNF\u03b1 increase Thymic Stromal Lymphopoietin Receptor (TSLPR) expression on eosinophils and enhance TSLP-stimulated degranulation","volume":"10","author":"Cook","year":"2012","journal-title":"Clin Mol Allergy"},{"key":"2025091922215242600_CIT0085","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/iid3.161","article-title":"Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps","volume":"5","author":"Poposki","year":"2017","journal-title":"Immun Inflamm Dis"},{"key":"2025091922215242600_CIT0086","doi-asserted-by":"publisher","first-page":"2101296","DOI":"10.1183\/13993003.01296-2021","article-title":"The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM)","volume":"59","author":"Sverrild","year":"2022","journal-title":"Eur Respir J"},{"key":"2025091922215242600_CIT0087","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/S2213-2600(21)00226-5","article-title":"Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"9","author":"Diver","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2025091922215242600_CIT0088","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","article-title":"Tezepelumab in adults and adolescents with severe, uncontrolled asthma","volume":"384","author":"Menzies-Gow","year":"2021","journal-title":"N Engl J Med"},{"key":"2025091922215242600_CIT0089","doi-asserted-by":"publisher","first-page":"370","DOI":"10.4193\/Rhin17.045","article-title":"TSLP regulates eotaxin-1 production by nasal epithelial cells from patients with eosinophilic CRSwNP","volume":"56","author":"Wang","year":"2018","journal-title":"Rhinology"},{"key":"2025091922215242600_CIT0090","doi-asserted-by":"publisher","first-page":"e11450","DOI":"10.1371\/journal.pone.0011450","article-title":"Gene transcription changes in asthmatic chronic rhinosinusitis with nasal polyps and comparison to those in atopic dermatitis","volume":"5","author":"Plager","year":"2010","journal-title":"PLoS One"},{"key":"2025091922215242600_CIT0091","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/lary.20191","article-title":"Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients","volume":"119","author":"Yao","year":"2009","journal-title":"Laryngoscope"},{"key":"2025091922215242600_CIT0092","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jaci.2019.10.031","article-title":"An endothelial microRNA-1-regulated network controls eosinophil trafficking in asthma and chronic rhinosinusitis","volume":"145","author":"Korde","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0093","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fimmu.2019.00074","article-title":"Eotaxin-3 as a plasma biomarker for mucosal eosinophil infiltration in chronic rhinosinusitis","volume":"10","author":"Yamada","year":"2019","journal-title":"Front Immunol"},{"key":"2025091922215242600_CIT0094","doi-asserted-by":"publisher","first-page":"93","DOI":"10.12932\/AP-030417-0063","article-title":"Expression of cysteinyl leukotriene receptor GPR17 in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps","volume":"36","author":"Chen","year":"2018","journal-title":"Asian Pac J Allergy Immunol"},{"key":"2025091922215242600_CIT0095","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/1945892418807590","article-title":"Chronic rhinosinusitis\u2014could phenotyping or endotyping aid therapy","volume":"33","author":"Bayar Muluk","year":"2019","journal-title":"Am J Rhinol Allergy"},{"key":"2025091922215242600_CIT0096","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.7150\/ijbs.58427","article-title":"Livin in synergy with Ras induces and sustains corticosteroid resistance in the airway mucosa","volume":"17","author":"Xue","year":"2021","journal-title":"Int J Biol Sci"},{"key":"2025091922215242600_CIT0097","doi-asserted-by":"publisher","first-page":"8032","DOI":"10.3390\/ijms23148032","article-title":"Different roles of dendritic cells for chronic rhinosinusitis treatment according to phenotype","volume":"23","author":"Tai","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025091922215242600_CIT0098","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nri2275","article-title":"Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma","volume":"8","author":"Hammad","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"2025091922215242600_CIT0099","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41590-024-01803-2","article-title":"TCF1-LEF1 co-expression identifies a multipotent progenitor cell (T(H)2-MPP) across human allergic diseases","volume":"25","author":"Kratchmarov","year":"2024","journal-title":"Nat Immunol"},{"key":"2025091922215242600_CIT0100","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.chest.2019.04.101","article-title":"Group 2 innate lymphoid cells in airway diseases","volume":"156","author":"Kato","year":"2019","journal-title":"Chest"},{"key":"2025091922215242600_CIT0101","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41385-019-0215-8","article-title":"Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps","volume":"13","author":"Ogasawara","year":"2020","journal-title":"Mucosal Immunol"},{"key":"2025091922215242600_CIT0102","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.immuni.2012.08.015","article-title":"The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells","volume":"37","author":"Mj\u00f6sberg","year":"2012","journal-title":"Immunity"},{"key":"2025091922215242600_CIT0103","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000518924","article-title":"The underestimated role of mast cells in the pathogenesis of rhinopathies","volume":"183","author":"Gelardi","year":"2022","journal-title":"Int Arch Allergy Immunol"},{"key":"2025091922215242600_CIT0104","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41577-022-00735-y","article-title":"Role of thymic stromal lymphopoietin in allergy and beyond","volume":"23","author":"Ebina-Shibuya","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"2025091922215242600_CIT0105","doi-asserted-by":"publisher","first-page":"eabb7221","DOI":"10.1126\/sciimmunol.abb7221","article-title":"Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation","volume":"6","author":"Dwyer","year":"2021","journal-title":"Sci Immunol"},{"key":"2025091922215242600_CIT0106","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.jaci.2015.10.020","article-title":"Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease","volume":"137","author":"Buchheit","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0107","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.anai.2014.09.017","article-title":"Correlation of basophil infiltration in nasal polyps with the severity of chronic rhinosinusitis","volume":"114","author":"Kagoya","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2025091922215242600_CIT0108","doi-asserted-by":"publisher","first-page":"1190034","DOI":"10.3389\/fimmu.2023.1190034","article-title":"Basophils beyond allergic and parasitic diseases","volume":"14","author":"Poto","year":"2023","journal-title":"Front Immunol"},{"key":"2025091922215242600_CIT0109","doi-asserted-by":"publisher","first-page":"1047930","DOI":"10.3389\/fimmu.2022.1047930","article-title":"M2 macrophage-related gene signature in chronic rhinosinusitis with nasal polyps","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Immunol"},{"key":"2025091922215242600_CIT0110","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jaci.2013.02.003","article-title":"Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps","volume":"132","author":"Takabayashi","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0111","doi-asserted-by":"publisher","first-page":"2301397","DOI":"10.1183\/13993003.01397-2023","article-title":"The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma","volume":"63","author":"Russell","year":"2024","journal-title":"Eur Respir J"},{"key":"2025091922215242600_CIT0112","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1177\/19458924231193154","article-title":"TSLP induces epithelial-mesenchymal transition in nasal epithelial cells from allergic rhinitis patients through TGF-\u03b21\/Smad2\/3 signaling","volume":"37","author":"Yu","year":"2023","journal-title":"Am J Rhinol Allergy"},{"key":"2025091922215242600_CIT0113","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1080\/01902148.2018.1536175","article-title":"TSLP promotes asthmatic airway remodeling via p38-STAT3 signaling pathway in human lung fibroblast","volume":"44","author":"Cao","year":"2018","journal-title":"Exp Lung Res"},{"key":"2025091922215242600_CIT0114","doi-asserted-by":"publisher","first-page":"119083","DOI":"10.1016\/j.bbamcr.2021.119083","article-title":"TSLP-induced collagen type-I synthesis through STAT3 and PRMT1 is sensitive to calcitriol in human lung fibroblasts","volume":"1868","author":"Jin","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2025091922215242600_CIT0115","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/cbf.2926","article-title":"Thymic stromal lymphopoietin promotes asthmatic airway remodelling in human lung fibroblast cells through STAT3 signalling pathway","volume":"31","author":"Wu","year":"2013","journal-title":"Cell Biochem Funct"},{"key":"2025091922215242600_CIT0116","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/01902148.2019.1646841","article-title":"Thymic stromal lymphopoietin induced early stage of epithelial-mesenchymal transition in human bronchial epithelial cells through upregulation of transforming growth factor beta 1","volume":"45","author":"Cai","year":"2019","journal-title":"Exp Lung Res"},{"key":"2025091922215242600_CIT0117","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1164\/rccm.200811-1730OC","article-title":"Induction of epithelial\u2013mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-\u03b21","volume":"180","author":"Hackett","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2025091922215242600_CIT0118","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3389\/fimmu.2020.00761","article-title":"More than just a barrier: the immune functions of the airway epithelium in asthma pathogenesis","volume":"11","author":"Frey","year":"2020","journal-title":"Front Immunol"},{"key":"2025091922215242600_CIT0119","doi-asserted-by":"publisher","first-page":"7678","DOI":"10.4049\/jimmunol.178.12.7678","article-title":"Down-regulation of E-cadherin in human bronchial epithelial cells leads to epidermal growth factor receptor-dependent Th2 cell-promoting activity","volume":"178","author":"Heijink","year":"2007","journal-title":"J Immunol"},{"key":"2025091922215242600_CIT0120","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/aji.12104","article-title":"Cervical carcinoma cells stimulate the angiogenesis through TSLP promoting growth and activation of vascular endothelial cells","volume":"70","author":"Xie","year":"2013","journal-title":"Am J Reprod Immunol"},{"key":"2025091922215242600_CIT0121","doi-asserted-by":"publisher","first-page":"7483","DOI":"10.3892\/ol.2017.7121","article-title":"TSLP promotes angiogenesis of human umbilical vein endothelial cells by strengthening the crosstalk between cervical cancer cells and eosinophils","volume":"14","author":"Zhang","year":"2017","journal-title":"Oncol Lett"},{"key":"2025091922215242600_CIT0122","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.3390\/cells10082012","article-title":"Human lung-resident macrophages express and are targets of thymic stromal lymphopoietin in the tumor microenvironment","volume":"10","author":"Braile","year":"2021","journal-title":"Cells"},{"key":"2025091922215242600_CIT0123","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s12070-023-03469-y","article-title":"Differential angiogenic induction impacts nasal polyp tissue growth","volume":"75","author":"de G\u00f3es","year":"2023","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"2025091922215242600_CIT0124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.ai.2019.05.001","article-title":"The airway epithelium in asthma","volume":"142","author":"Bonser","year":"2019","journal-title":"Adv Immunol"},{"key":"2025091922215242600_CIT0125","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.4049\/jimmunol.1700216","article-title":"The innate cytokines IL-25, IL-33, and TSLP cooperate in the induction of type 2 innate lymphoid cell expansion and mucous metaplasia in rhinovirus-infected immature mice","volume":"199","author":"Han","year":"2017","journal-title":"J Immunol"},{"key":"2025091922215242600_CIT0126","doi-asserted-by":"publisher","first-page":"A32","DOI":"10.1136\/thorax-2022-BTSabstracts.52","article-title":"S46 Tezepelumab reduces mucus plugging in patients with uncontrolled, moderate-to-severe asthma: the phase 2 CASCADE study","volume":"77","author":"Nordenmark","year":"2022","journal-title":"Thorax"},{"key":"2025091922215242600_CIT0127","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1172\/JCI13557","article-title":"IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells","volume":"108","author":"Laoukili","year":"2001","journal-title":"J Clin Invest"},{"key":"2025091922215242600_CIT0128","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nm734","article-title":"Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma","volume":"8","author":"Kuperman","year":"2002","journal-title":"Nat Med"},{"key":"2025091922215242600_CIT0129","doi-asserted-by":"publisher","first-page":"450","DOI":"10.2500\/aap.2021.42.210080","article-title":"Treatment options for chronic rhinosinusitis with nasal polyps","volume":"42","author":"Wallace","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"2025091922215242600_CIT0130","doi-asserted-by":"publisher","first-page":"e36024","DOI":"10.1097\/MD.0000000000036024","article-title":"Research progress of glucocorticoid resistance in chronic rhinosinusitis with nasal polyps: a review","volume":"102","author":"Chen","year":"2023","journal-title":"Medicine (Baltim)"},{"key":"2025091922215242600_CIT0131","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12865-015-0096-x","article-title":"Clarithromycin and dexamethasone show similar anti-inflammatory effects on distinct phenotypic chronic rhinosinusitis: an explant model study","volume":"16","author":"Zeng","year":"2015","journal-title":"BMC Immunol"},{"key":"2025091922215242600_CIT0132","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/alr.21436","article-title":"Verapamil modulates interleukin-5 and interleukin-6 secretion in organotypic human sinonasal polyp explants","volume":"5","author":"Bleier","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"key":"2025091922215242600_CIT0133","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/alr.22641","article-title":"Lipopolysaccharide regulates thymic stromal lymphopoietin expression via TLR4\/MAPK\/Akt\/NF-\u03baB\u2013signaling pathways in nasal fibroblasts: differential inhibitory effects of macrolide and corticosteroid","volume":"11","author":"Kang","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"2025091922215242600_CIT0134","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.plefa.2017.09.009","article-title":"The role of cysteinyl leukotrienes and their receptors in refractory nasal polyps","volume":"126","author":"Du","year":"2017","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2025091922215242600_CIT0135","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1016\/j.jaip.2023.04.054","article-title":"The management of chronic rhinosinusitis with nasal polyps (CRSwNP) with biologics","volume":"11","author":"Wautlet","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025091922215242600_CIT0136","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4193\/Rhin22.489","article-title":"EPOS\/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023","volume":"61","author":"Fokkens","year":"2023","journal-title":"Rhinology"},{"key":"2025091922215242600_CIT0137","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jaci.2021.10.029","article-title":"Biologics for chronic rhinosinusitis with nasal polyps (CRSwNP)","volume":"149","author":"Scadding","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0138","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2217\/imt-2021-0310","article-title":"A review of phase III clinical trials of US FDA-approved biologic therapies for chronic rhinosinusitis with nasal polyposis","volume":"14","author":"Lelegren","year":"2022","journal-title":"Immunotherapy"},{"key":"2025091922215242600_CIT0139","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1056\/NEJMoa2414482","article-title":"Tezepelumab in adults with severe chronic rhinosinusitis with nasal polyps","volume":"392","author":"Lipworth","year":"2025","journal-title":"N Engl J Med"},{"key":"2025091922215242600_CIT0140","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2147\/JAA.S413064","article-title":"Tezepelumab efficacy in patients with severe, uncontrolled asthma with comorbid nasal polyps in NAVIGATOR","volume":"16","author":"Laidlaw","year":"2023","journal-title":"J Asthma Allergy"},{"key":"2025091922215242600_CIT0141","doi-asserted-by":"publisher","first-page":"AB100","DOI":"10.1016\/j.jaci.2023.11.329","article-title":"Efficacy of biologics in patients with moderate-to-severe, uncontrolled asthma and nasal polyps","volume":"153","author":"Peters","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0142","first-page":"A5983","article-title":"Tezepelumab efficacy by SNOT-22 domain scores in patients with severe, uncontrolled asthma and comorbid nasal polyps in the phase 3 NAVIGATOR study","volume-title":"Am J Respir Crit Care Med","author":"Spahn","year":"2023"},{"key":"2025091922215242600_CIT0143","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1056\/NEJMoa1704064","article-title":"Tezepelumab in adults with uncontrolled asthma","volume":"377","author":"Corren","year":"2017","journal-title":"N Engl J Med"},{"key":"2025091922215242600_CIT0144","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S2213-2600(24)00324-2","article-title":"Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial","volume":"13","author":"Singh","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2025091922215242600_CIT0145","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jaad.2018.11.059","article-title":"Tezepelumab, an anti-thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: a randomized phase 2a clinical trial","volume":"80","author":"Simpson","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2025091922215242600_CIT0146","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.jaci.2025.01.045","article-title":"Tezepelumab for the treatment of chronic spontaneous urticaria: results of the phase 2b INCEPTION study","volume":"155","author":"McLaren","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"2025091922215242600_CIT0147","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/all.15918","article-title":"Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma","volume":"79","author":"Sverrild","year":"2024","journal-title":"Allergy"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cei\/advance-article-pdf\/doi\/10.1093\/cei\/uxaf041\/64220057\/uxaf041.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/219\/1\/uxaf041\/64220057\/uxaf041.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/219\/1\/uxaf041\/64220057\/uxaf041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T02:22:03Z","timestamp":1758334923000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/doi\/10.1093\/cei\/uxaf041\/8249034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":147,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,21]]}},"URL":"https:\/\/doi.org\/10.1093\/cei\/uxaf041","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"uxaf041"}}